Compare IQV & YUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | YUM |
|---|---|---|
| Founded | 1982 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 42.6B |
| IPO Year | 2013 | 1997 |
| Metric | IQV | YUM |
|---|---|---|
| Price | $235.75 | $156.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 20 |
| Target Price | ★ $242.60 | $165.44 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.30 | 5.13 |
| Revenue | ★ $15,904,000,000.00 | $8,061,000,000.00 |
| Revenue This Year | $6.14 | $9.14 |
| Revenue Next Year | $5.44 | $9.73 |
| P/E Ratio | $32.26 | ★ $30.29 |
| Revenue Growth | 3.85 | ★ 11.60 |
| 52 Week Low | $134.65 | $128.73 |
| 52 Week High | $247.05 | $163.30 |
| Indicator | IQV | YUM |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 55.70 |
| Support Level | $227.99 | $151.60 |
| Resistance Level | $244.16 | $154.89 |
| Average True Range (ATR) | 5.81 | 2.93 |
| MACD | -0.83 | -0.30 |
| Stochastic Oscillator | 39.14 | 45.93 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
As of the end of 2024, Yum Brands generated over $65 billion in systemwide sales from more than 61,000 restaurants across 155 markets, making it the world's second-largest restaurant firm by dollar sales. Its portfolio includes KFC (31,981 stores), Pizza Hut (20,225), Taco Bell (8,757), and Habit Burger (383), with 70% of locations in international markets. As 98% of its portfolio is franchised, Yum's business model is tilted toward recurring franchise royalties and marketing contributions (66% of revenue), with the balance derived from sales at company-owned locations. The company traces its roots to a 1997 spinoff of PepsiCo's restaurant assets.